{"meta":{"query_hash":"8b687e27cfd6","filters":{"venue":"Journal of Crohn s and Colitis Supplements"},"cohort_total":15,"direct_labels_cover":0,"predictions_cover":15,"exported":15,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8b687e27cfd6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Crohn+s+and+Colitis+Supplements"},"results":[{"id":"W1979073250","doi":"10.1016/s1873-9954(09)70058-8","title":"P044 IDENTIFYING CHILDREN DIAGNOSED WITH IBD USING HEALTH ADMINISTRATIVE DATA: DEVELOPMENT OF THE ONTARIO CROHN'S AND COLITIS COHORT (OCCC)","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Colitis; Crohn's disease; Internal medicine; Disease","score_opus":0.20609609435970558,"score_gpt":0.4456838337945426,"score_spread":0.23958773943483705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979073250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620533,0.00020773617,0.0006877426,0.0012557427,0.0002481888,0.0010024366,0.00017274143,0.0000052813966,0.00021478368],"genre_scores_gemma":[0.992706,0.00034037462,0.0049486095,0.0016575899,0.00013590985,0.000009756262,0.00007232102,0.000008673699,0.000120784156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689186,0.00026663195,0.0015248535,0.00017477511,0.0006609387,0.00048095995],"domain_scores_gemma":[0.99747926,0.00013490803,0.0015245866,0.00022450511,0.00026853528,0.00036818458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018557698,0.00016136776,0.00048641028,0.00009665896,0.0012595555,0.000044784603,0.00024117641,0.00008715285,0.00019477552],"category_scores_gemma":[0.00008958692,0.00010878657,0.00002899425,0.00011940137,0.000087129076,0.00042563045,0.00013402328,0.00059242063,8.417752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011838871,0.00017971292,0.9406635,0.00050173677,0.00019245879,0.000034007346,0.031753488,0.0000016330305,0.0000018382291,0.00045701163,0.007859263,0.01717145],"study_design_scores_gemma":[0.0023477639,0.00032781038,0.981636,0.0014458977,0.00004912462,0.00006905576,0.0023908503,0.000019559415,0.0000148464,0.00011338787,0.011482743,0.00010300295],"about_ca_topic_score_codex":0.0058737937,"about_ca_topic_score_gemma":0.027982518,"teacher_disagreement_score":0.040972445,"about_ca_system_score_codex":0.00040450264,"about_ca_system_score_gemma":0.0035387208,"threshold_uncertainty_score":0.98975426},"labels":[],"label_agreement":null},{"id":"W2028602994","doi":"10.1016/s1873-9954(09)70037-0","title":"P023 CROHN'S DISEASE PRESENTATION IN PEDIATRIC PATIENTS","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Presentation (obstetrics); Crohn's disease; Medicine; Disease; Pediatrics; Intensive care medicine; Internal medicine; Surgery","score_opus":0.006429205289719926,"score_gpt":0.24443606949080082,"score_spread":0.2380068642010809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028602994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914658,0.0073406096,0.000019992958,0.00033207904,0.00037718774,0.000182942,0.000034712146,0.0000048260417,0.00024182645],"genre_scores_gemma":[0.99853104,0.00084562897,0.000012441846,0.00023311198,0.000012113437,0.0000035690234,0.00006690576,0.0000056543495,0.0002895598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988575,0.000100425474,0.00053986086,0.00012366638,0.000083730694,0.00029479712],"domain_scores_gemma":[0.9994742,0.000030599655,0.0002712908,0.0000923899,0.000111183916,0.000020336773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018185185,0.00012162024,0.00021155462,0.00021098315,0.000118188276,0.000031769803,0.00014770878,0.00006225354,0.00028151338],"category_scores_gemma":[0.0000505811,0.000108565386,0.00007564782,0.00014054839,0.000044868033,0.00027736294,0.00002646978,0.00018528741,0.000014112334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007566087,0.004714881,0.83021104,0.000111677495,0.00013794133,0.0004040541,0.0028899922,0.000040852658,0.0006438376,0.0016983014,0.01248765,0.1390937],"study_design_scores_gemma":[0.004276383,0.00025364987,0.98363864,0.000026238042,0.000041559815,0.0000072607027,0.0001935451,0.0000016784027,0.00011104837,0.0009770093,0.010362041,0.00011096317],"about_ca_topic_score_codex":0.000031124717,"about_ca_topic_score_gemma":0.0000038421504,"teacher_disagreement_score":0.15342759,"about_ca_system_score_codex":0.000029171642,"about_ca_system_score_gemma":0.000068011694,"threshold_uncertainty_score":0.4427168},"labels":[],"label_agreement":null},{"id":"W2031417477","doi":"10.1016/s1873-9954(09)70023-0","title":"P009 DETERMINANTS OF CORTICOSTEROID-RESISTANCE IN SEVERE PEDIATRIC ULCERATIVE COLITIS","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Ulcerative colitis; Corticosteroid; Medicine; Resistance (ecology); Internal medicine; Gastroenterology; Biology; Disease","score_opus":0.012343497250717272,"score_gpt":0.29147870562679923,"score_spread":0.27913520837608197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031417477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970765,0.0006837216,0.000117818585,0.00036494154,0.00006893489,0.0004802596,0.000057824072,0.00000979139,0.001140173],"genre_scores_gemma":[0.99386257,0.0024831502,0.0027153508,0.00039821988,0.00017046949,0.000007106933,0.0000050573526,0.000010508345,0.00034755812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792254,0.00009579771,0.0010129488,0.00016578668,0.0004833817,0.00031955566],"domain_scores_gemma":[0.9987189,0.00006916886,0.00065176404,0.00015818865,0.00024092532,0.00016105891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000493037,0.0001649328,0.0005882147,0.00040114057,0.000040218518,0.00002771657,0.00013522865,0.00007012348,0.00010748374],"category_scores_gemma":[0.000113729075,0.00015308864,0.000094984855,0.0002889215,0.000042154257,0.00024539998,0.000041119452,0.00019109451,8.950253e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032809079,0.0006125751,0.9653095,0.0003224127,0.0000504283,0.0016582755,0.000537406,3.2641879e-7,0.000046115252,0.00020657947,0.016310353,0.011665107],"study_design_scores_gemma":[0.003771959,0.001005552,0.98991704,0.00021048242,0.00014603455,0.00012957891,0.00013005521,0.00000898403,0.00023125425,0.0025367558,0.0017845143,0.0001277674],"about_ca_topic_score_codex":0.000027619926,"about_ca_topic_score_gemma":0.00019242319,"teacher_disagreement_score":0.024607548,"about_ca_system_score_codex":0.000119869874,"about_ca_system_score_gemma":0.00012986881,"threshold_uncertainty_score":0.62427735},"labels":[],"label_agreement":null},{"id":"W2040332548","doi":"10.1016/s1873-9954(08)70054-5","title":"P043 LONG-TERM STEROID-FREE REMISSION IN CROHN'S PATIENTS RECEIVING ADALIMUMAB: THE CHARM TRIAL","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Charm (quantum number); Adalimumab; Term (time); Medicine; Steroid use; Crohn's disease; Internal medicine; Physics; Particle physics","score_opus":0.012253515520056706,"score_gpt":0.25624824434338095,"score_spread":0.24399472882332424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040332548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986186,0.00022128054,0.000023387469,0.00014571118,0.00038229118,0.0003976161,0.000061955216,0.0000021174517,0.00014703593],"genre_scores_gemma":[0.99821687,0.00064844085,0.000064813314,0.00023412789,0.0004241606,0.000014145191,0.000041999097,0.000019466435,0.00033598806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839133,0.00015577931,0.00060326036,0.00018849243,0.00036203238,0.0002991329],"domain_scores_gemma":[0.9989891,0.00001615743,0.00036057792,0.00029197586,0.00017671556,0.0001654607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033398968,0.00016470494,0.00019791427,0.00006985415,0.00017575242,0.000041140054,0.00031126192,0.00009261587,0.000117136],"category_scores_gemma":[0.00013695243,0.00012415099,0.0001164806,0.00005249656,0.000082604914,0.000023727553,0.00019986907,0.00015845912,0.0000015127141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06526881,0.0007288906,0.900685,0.000074012045,0.00014584283,0.0018903972,0.0005138848,0.0000047047033,0.0011436208,0.000021334794,0.020919427,0.008604036],"study_design_scores_gemma":[0.03082609,0.00042399246,0.9629167,0.00007365342,0.000023455586,0.00006781622,0.00003892269,0.0000023481473,0.00095684116,0.000029095461,0.0045026788,0.00013842978],"about_ca_topic_score_codex":0.000012228999,"about_ca_topic_score_gemma":0.00010923258,"teacher_disagreement_score":0.062231638,"about_ca_system_score_codex":0.000044174598,"about_ca_system_score_gemma":0.000148172,"threshold_uncertainty_score":0.50627303},"labels":[],"label_agreement":null},{"id":"W2041701536","doi":"10.1016/s1873-9954(09)70035-7","title":"P021 TRANSIENT HYPERTRANSAMINASEMIA IN PEDIATRIC PATIENTS WITH CROHN'S DISEASE UNDERGOING INITIAL TREATMENT WITH ENTERAL NUTRITION","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Parenteral nutrition; Enteral administration; Crohn's disease; Crohn disease; Pediatrics; Disease; Intensive care medicine; Internal medicine","score_opus":0.0046758147378076625,"score_gpt":0.2249151943841396,"score_spread":0.22023937964633195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041701536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891496,0.0002332471,0.00011378933,0.00010453638,0.000044648277,0.0003828163,0.00016324308,0.0000022151125,0.000040540413],"genre_scores_gemma":[0.99878395,0.00050667755,0.00018219108,0.00012468829,0.00018558883,0.000018526756,0.00016404859,0.0000140183365,0.00002034374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988886,0.00006100031,0.00033567986,0.0001933431,0.00025532243,0.00026603957],"domain_scores_gemma":[0.9993547,0.000006950835,0.00015013423,0.00010870309,0.00013129757,0.0002481936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054781543,0.00018779545,0.00017725698,0.000107948064,0.00006712321,0.00004720304,0.00007184586,0.000044309178,0.000029255054],"category_scores_gemma":[0.0000051223615,0.00014335067,0.00006967803,0.000060984577,0.000033431716,0.000030769625,0.00000762896,0.000064790736,3.8317498e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042385254,0.0040001,0.940161,0.00018747637,0.00014348136,0.0061653317,0.00026466316,0.00006551701,0.00016744925,0.000027616736,0.00050612184,0.0059259958],"study_design_scores_gemma":[0.013599859,0.002823991,0.981858,0.00010334993,0.00012983005,0.000023144628,0.000058634967,0.000004030868,0.00023713236,0.000025895743,0.0009593803,0.00017672141],"about_ca_topic_score_codex":0.000005956672,"about_ca_topic_score_gemma":0.00020136217,"teacher_disagreement_score":0.041697036,"about_ca_system_score_codex":0.00006708314,"about_ca_system_score_gemma":0.00021785671,"threshold_uncertainty_score":0.58456707},"labels":[],"label_agreement":null},{"id":"W2044870710","doi":"10.1016/s1873-9954(09)70024-2","title":"P010 PANETH CELLS: A SOURCE OF THE PRO-INFLAMMATORY CYTOKINE TNF-ALPHA","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Cytokine; Tumor necrosis factor alpha; Alpha (finance); Cell biology; Immunology; Medicine; Biology","score_opus":0.00933684671081425,"score_gpt":0.22516806489024657,"score_spread":0.21583121817943232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044870710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625957,0.00093806826,0.00006818875,0.0003053845,0.0006376036,0.00024411143,0.00068056013,0.000007720423,0.00085878576],"genre_scores_gemma":[0.99735814,0.0004161305,0.00007467962,0.00031983657,0.00011754322,0.0000026548184,0.000013322136,0.0000101597625,0.0016875196],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985754,0.00016450592,0.0006617131,0.00013414393,0.00011470033,0.00034953078],"domain_scores_gemma":[0.9989472,0.00004659916,0.0005656348,0.00019677599,0.00019705693,0.000046706722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035912657,0.00016790292,0.00037198537,0.00008551135,0.00019205367,0.000021110161,0.0002875956,0.0001386524,0.00031504384],"category_scores_gemma":[0.000037074322,0.00011341368,0.00015009331,0.00009555341,0.00015972131,0.000120306824,0.00006749757,0.000320824,0.000011399248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004852587,0.0017463992,0.024078682,0.0003567449,0.001231953,0.00023937823,0.008676205,0.000014492051,0.7202521,0.0038016092,0.1616748,0.07307504],"study_design_scores_gemma":[0.003495938,0.0008486909,0.1508367,0.00013854717,0.00010739676,0.00042279135,0.0005966264,0.0000012074455,0.19619119,0.0006360107,0.64655894,0.00016595692],"about_ca_topic_score_codex":0.000038108665,"about_ca_topic_score_gemma":0.000027740294,"teacher_disagreement_score":0.5240609,"about_ca_system_score_codex":0.000029772751,"about_ca_system_score_gemma":0.0001611531,"threshold_uncertainty_score":0.46248755},"labels":[],"label_agreement":null},{"id":"W2046667750","doi":"10.1016/s1873-9954(07)70024-1","title":"P012 CD-68 POSITIVE CELLS IN BUCCAL MUCOSA AS DIAGNOSTIC MARKER FOR IBD","year":2007,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Buccal mucosa; Ulcerative colitis; Medicine; Buccal administration; Inflammatory bowel disease; Saliva; Candida albicans; Gastrointestinal tract; Gastroenterology; Pathology; Population; Oral cavity; Oral mucosa; Internal medicine; Disease; Dentistry; Biology; Microbiology","score_opus":0.005839724707012261,"score_gpt":0.2519954179815904,"score_spread":0.24615569327457815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046667750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986932,0.010001449,0.0004561515,0.000284331,0.00095651526,0.00038120133,0.00017043576,0.0000063063717,0.00081165537],"genre_scores_gemma":[0.99821013,0.00055289327,0.000091887865,0.00035193417,0.000016741937,0.000010196211,0.00005736811,0.000013829623,0.0006950259],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984172,0.00009194362,0.00070645765,0.00016090344,0.000070443035,0.0005530674],"domain_scores_gemma":[0.9988699,0.000587835,0.00027880468,0.00009875304,0.00014226646,0.000022444761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082766736,0.00017167692,0.00034740666,0.00019556067,0.00017979156,0.000030165158,0.0001747141,0.00015195688,0.000585267],"category_scores_gemma":[0.00015105291,0.00015371345,0.00013636932,0.00010559519,0.00014259806,0.00017142533,0.00005639535,0.00028138707,0.000030546435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053427283,0.010784441,0.11583082,0.0005685717,0.0032428687,0.0029437938,0.020981869,0.000039455266,0.25531697,0.02272383,0.05443614,0.45970398],"study_design_scores_gemma":[0.008663842,0.0010186251,0.742389,0.0001847538,0.00008811716,0.00039689688,0.0029479496,0.0000022016548,0.027271364,0.0012108784,0.21553749,0.00028886108],"about_ca_topic_score_codex":0.00021677569,"about_ca_topic_score_gemma":0.000046797366,"teacher_disagreement_score":0.6265582,"about_ca_system_score_codex":0.000054820488,"about_ca_system_score_gemma":0.00008599485,"threshold_uncertainty_score":0.6408263},"labels":[],"label_agreement":null},{"id":"W2054399435","doi":"10.1016/s1873-9954(07)70080-0","title":"P068 NATALIZUMAB MAINTAINS REMISSION FOR 2 YEARS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE AND IN THOSE WITH PRIOR INFLIXIMAB EXPOSURE: RESULTS FROM AN OPEN-LABEL EXTENSION STUDY","year":2007,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Natalizumab; Infliximab; Crohn's disease; Medicine; Open label; Disease; Internal medicine; Extension (predicate logic); Gastroenterology; Adverse effect; Computer science","score_opus":0.0167947458870927,"score_gpt":0.2927308397466874,"score_spread":0.2759360938595947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054399435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971185,0.0005942766,0.00007688939,0.00009006713,0.00008599229,0.001565287,0.00045155635,0.0000041490757,0.0000133009],"genre_scores_gemma":[0.999242,0.000035360325,0.0002784887,0.00015127374,0.000004023655,0.000024312683,0.00018718922,0.000020469912,0.000056869903],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983123,0.00014459158,0.00064719573,0.00036347946,0.00012995828,0.00040250114],"domain_scores_gemma":[0.9991293,0.000089471614,0.00031571172,0.00020314503,0.00020182438,0.00006055367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057011534,0.00020929001,0.00039914693,0.000226334,0.00018834588,0.00008440303,0.0002342179,0.000085086656,0.000016768772],"category_scores_gemma":[0.00007767267,0.00016093299,0.000016459635,0.00016075105,0.000074957185,0.0005409148,0.00014580667,0.00024109869,5.746597e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8492692,0.009442716,0.04866672,0.000024710298,0.00026156584,0.00076711836,0.014488748,0.0000570997,0.0004952012,0.000042565647,0.0001220551,0.07636231],"study_design_scores_gemma":[0.051951353,0.004553968,0.937285,0.0002788057,0.000049187645,0.000010129922,0.004571491,0.0000066324505,0.00023059761,0.00013250859,0.00071167154,0.00021866127],"about_ca_topic_score_codex":0.0006774727,"about_ca_topic_score_gemma":0.0006144563,"teacher_disagreement_score":0.8886183,"about_ca_system_score_codex":0.00009228246,"about_ca_system_score_gemma":0.00015411549,"threshold_uncertainty_score":0.65626574},"labels":[],"label_agreement":null},{"id":"W2058023266","doi":"10.1016/s1873-9954(09)70025-4","title":"P011 FAECAL OSTEOPROTEGRIN IN PAEDIATRIC CROHN DISEASE","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Crohn's disease; Medicine; Disease; Internal medicine","score_opus":0.006954247403952481,"score_gpt":0.24908127611164832,"score_spread":0.24212702870769584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058023266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993129,0.0058167093,0.000085402244,0.00037120678,0.00012789253,0.0001577127,0.00011918453,0.0000019418858,0.00019094214],"genre_scores_gemma":[0.99724066,0.001386207,0.00023080768,0.00050894846,0.00042075783,0.0000054406823,0.000036338934,0.000008118139,0.00016270572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890196,0.0000640365,0.00039985773,0.00016458877,0.00020989434,0.00025965497],"domain_scores_gemma":[0.9993193,0.00000644123,0.00015389269,0.00013392048,0.000086093525,0.0003003531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001736363,0.00013425814,0.00020186882,0.00010072528,0.000048473805,0.000049781956,0.00013187075,0.000057556957,0.00009278232],"category_scores_gemma":[0.00006345829,0.00011631497,0.00011013034,0.00008765971,0.000034469,0.00001595241,0.000052142066,0.000096627205,0.0000017888045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021807186,0.00397643,0.56772697,0.00023905412,0.00023926866,0.005331364,0.0003759693,0.00005129157,0.009159299,0.0028122975,0.07534235,0.3129385],"study_design_scores_gemma":[0.0023178114,0.00026995328,0.96043813,0.000019165911,0.000042990298,0.00003216469,0.00006685408,0.0000041885914,0.0008146728,0.0010832202,0.03477212,0.00013869735],"about_ca_topic_score_codex":0.000021208636,"about_ca_topic_score_gemma":0.000023298287,"teacher_disagreement_score":0.3927112,"about_ca_system_score_codex":0.000010453585,"about_ca_system_score_gemma":0.00013475028,"threshold_uncertainty_score":0.47431868},"labels":[],"label_agreement":null},{"id":"W2072542127","doi":"10.1016/s1873-9954(09)70005-9","title":"O04 INCIDENCE AND PREVALENCE OF CHILDHOOD-ONSET INFLAMMATORY BOWEL DISEASE IN ONTARIO, CANADA: RESULTS FROM THE ONTARIO CROHN'S AND COLITIS COHORT (OCCC)","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Microscopic Colitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Cohort; Inflammatory bowel disease; Crohn's disease; Internal medicine; Disease; Ulcerative colitis; Cohort study; Pediatrics; Gastroenterology","score_opus":0.006862195644053836,"score_gpt":0.23205383099571106,"score_spread":0.22519163535165723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072542127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526197,0.0012366188,0.0000018255171,0.0015073869,0.00012948253,0.0007216672,0.0010089586,0.0000030989083,0.00012900747],"genre_scores_gemma":[0.9971687,0.0009683184,0.00019077524,0.0008510201,0.00007871751,0.0000089341265,0.0000411167,0.000010661639,0.00068174704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974862,0.00011581436,0.0010767807,0.0003166031,0.0006173628,0.00038728814],"domain_scores_gemma":[0.9982965,0.00021531475,0.000499266,0.00030705697,0.00020237401,0.00047951032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053504517,0.00023509079,0.0005199093,0.00008875132,0.00013995195,0.00006537257,0.00017631077,0.000070889604,0.00044264318],"category_scores_gemma":[0.00023506183,0.00019360404,0.000056867357,0.00006797757,0.00017894374,0.00022188184,0.000113699396,0.00052287395,2.1462077e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003114685,0.00011496631,0.985846,0.0000773443,0.00007881941,0.0012803429,0.0033509794,8.5183257e-7,0.0000104986875,0.000031687956,0.0054013827,0.0006924812],"study_design_scores_gemma":[0.0050451704,0.00033405478,0.9848999,0.0012058085,0.00021161625,0.0002854768,0.00021421094,0.000003938302,0.000067030494,0.0004205635,0.0071500107,0.00016225263],"about_ca_topic_score_codex":0.9571787,"about_ca_topic_score_gemma":0.99385697,"teacher_disagreement_score":0.036678243,"about_ca_system_score_codex":0.0006954309,"about_ca_system_score_gemma":0.0036310046,"threshold_uncertainty_score":0.78949434},"labels":[],"label_agreement":null},{"id":"W2082377475","doi":"10.1016/s1873-9954(07)70026-5","title":"P014 ESOPHAGEAL STRICTURES IN EOSINOPHILIC ESOPHAGITIS: DILATION IS AN EFFECTIVE AND SAFE ALTERNATIVE AFTER FAILURE OF TOPICAL CORTICOSTEROIDS","year":2007,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Eosinophilic esophagitis; Medicine; Dilation (metric space); Dermatology; Gastroenterology; Internal medicine; Disease","score_opus":0.008486025470570124,"score_gpt":0.28672944734208516,"score_spread":0.278243421871515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082377475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967493,0.0018359728,0.00022250465,0.00034218215,0.00012369818,0.00052848854,0.00010103787,0.0000040819536,0.00009273909],"genre_scores_gemma":[0.9982083,0.00020613195,0.0008421533,0.00037312962,0.00028835566,0.000010338523,0.0000138454925,0.000018846964,0.00003890504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997963,0.00009592359,0.0008696967,0.00024019294,0.000513065,0.00031813973],"domain_scores_gemma":[0.99878067,0.00013274101,0.00037519133,0.00014974651,0.00026778475,0.00029386705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038709692,0.0002080591,0.00055017427,0.0003464975,0.00004432564,0.000038879465,0.00007695134,0.00012611914,0.00020630874],"category_scores_gemma":[0.00006854843,0.00018040731,0.00008040441,0.00016145,0.0001629764,0.00035307725,0.00006335271,0.00031183503,5.9721225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035378365,0.00043812927,0.9487864,0.0001542612,0.00016685556,0.002298581,0.0033701623,0.0000010901388,0.0006981905,0.00026476805,0.000108027074,0.040175743],"study_design_scores_gemma":[0.0056815096,0.0024737364,0.9801876,0.0002540865,0.000121755205,0.000771096,0.00037874223,0.000026937785,0.00859698,0.0012256822,0.00016209393,0.00011977828],"about_ca_topic_score_codex":0.00015068027,"about_ca_topic_score_gemma":0.000255389,"teacher_disagreement_score":0.040055964,"about_ca_system_score_codex":0.00011992919,"about_ca_system_score_gemma":0.00005106764,"threshold_uncertainty_score":0.7356797},"labels":[],"label_agreement":null},{"id":"W2083269457","doi":"10.1016/s1873-9954(08)70010-7","title":"9 ASSESSMENT OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF CROHN'S DISEASE IN PATIENTS FOR WHOM INFLIXIMAB TREATMENT WAS NOT SUCCESSFUL: OPEN-LABEL INDUCTION PRELIMINARY RESULTS FROM THE WELCOME STUDY","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Certolizumab pegol; Infliximab; Medicine; Crohn's disease; Open label; Adalimumab; Disease; Internal medicine; Clinical trial","score_opus":0.06588458941485871,"score_gpt":0.3734134110423851,"score_spread":0.3075288216275264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083269457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324,0.0002154372,0.0000038604207,0.0010436334,0.00012869538,0.004437939,0.00087692286,0.0000017508426,0.000051746498],"genre_scores_gemma":[0.9982143,0.0008898023,0.00017978811,0.000032988642,0.000119069446,0.0002990144,0.00015490518,0.000020060077,0.000090062174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966897,0.0003277883,0.0013614985,0.00029423897,0.0009727406,0.00035405235],"domain_scores_gemma":[0.9978486,0.00054367114,0.0006513731,0.000472981,0.00032749318,0.00015592249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033031925,0.00024269134,0.0007362521,0.00019729068,0.00016565672,0.000059794682,0.00036220616,0.000060463197,0.00003406763],"category_scores_gemma":[0.00010303014,0.00013440986,0.00011311776,0.00023062051,0.00016458429,0.00024318983,0.000109964276,0.00014313478,2.9882133e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16713952,0.059479132,0.73101234,0.00014496717,0.0009971851,0.0033103575,0.02332675,0.00004295289,0.000020094933,0.000047922673,0.001229767,0.013248998],"study_design_scores_gemma":[0.16958635,0.019523859,0.8064343,0.00018965937,0.00025450904,0.00006315162,0.0023069067,0.0004111608,0.00011931185,0.000048696005,0.0009741803,0.00008793019],"about_ca_topic_score_codex":0.011162008,"about_ca_topic_score_gemma":0.0009959815,"teacher_disagreement_score":0.075421944,"about_ca_system_score_codex":0.0045075943,"about_ca_system_score_gemma":0.003114434,"threshold_uncertainty_score":0.99931395},"labels":[],"label_agreement":null},{"id":"W3022084089","doi":"10.1016/s1873-9954(09)70009-6","title":"O08 METHOTREXATE IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: AN 8 YEAR RETROSPECTIVE STUDY IN A CANADIAN PEDIATRIC IBD CENTER","year":2009,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammatory bowel disease; Medicine; Methotrexate; Retrospective cohort study; Center (category theory); Disease; Inflammatory Bowel Diseases; Internal medicine; Pediatrics","score_opus":0.007548643257987481,"score_gpt":0.26978055570779896,"score_spread":0.2622319124498115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022084089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897116,0.00025556693,9.758651e-7,0.0000802821,0.00004829084,0.00040798075,0.00015167925,6.5504685e-7,0.00008341903],"genre_scores_gemma":[0.999196,0.000476354,0.000029493563,0.000086034765,0.00014996478,0.000009174824,0.000023899875,0.000007682228,0.0000214309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987792,0.00021603775,0.0003954793,0.0001499875,0.00019795122,0.00026134696],"domain_scores_gemma":[0.9993221,0.000004493965,0.00016507097,0.00018632281,0.00008603411,0.00023596242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034459078,0.00012505047,0.00016059268,0.00017324883,0.000039848903,0.000027433227,0.00014722845,0.00003914394,0.000033119246],"category_scores_gemma":[0.000021162787,0.000095892516,0.00006886918,0.00007235734,0.000023436758,0.000017093424,0.000011095674,0.000064747284,4.402498e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010030011,0.00089272513,0.9954286,0.00000802735,0.000029084378,0.0010588986,0.0009823166,0.000005677799,0.000029533967,0.000041688523,0.00017642044,0.00034401618],"study_design_scores_gemma":[0.0033041458,0.0012329387,0.99298155,0.000008827901,0.00004339278,0.0000082921215,0.00076738425,0.0000047616354,0.000028516322,0.0001225917,0.0014090871,0.00008849404],"about_ca_topic_score_codex":0.0016878342,"about_ca_topic_score_gemma":0.057391204,"teacher_disagreement_score":0.05570337,"about_ca_system_score_codex":0.00011431493,"about_ca_system_score_gemma":0.00030619005,"threshold_uncertainty_score":0.95980895},"labels":[],"label_agreement":null},{"id":"W4232555127","doi":"10.1016/s1873-9954(08)70011-9","title":"10 LONG TERM OUTCOME AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY IN A COHORT OF 955 CANADIAN PATIENTS","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Quality of life (healthcare); Medicine; Proctocolectomy; Outcome (game theory); Term (time); Internal medicine; Ulcerative colitis; Nursing; Disease","score_opus":0.035231636552715495,"score_gpt":0.32367154848711177,"score_spread":0.2884399119343963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232555127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818134,0.00023668977,8.637817e-7,0.000099254765,0.000034100107,0.0008784846,0.00014637304,0.0000011371993,0.00042176413],"genre_scores_gemma":[0.99941665,0.00008741034,0.0000800937,0.00009804681,0.000023244213,0.00005273902,0.000012583049,0.000008866664,0.00022038093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822915,0.000084773535,0.00092415366,0.00013331563,0.0004113095,0.00021731935],"domain_scores_gemma":[0.9987049,0.000050671795,0.00041003886,0.00009557172,0.0003624323,0.00037640464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022276287,0.00012844478,0.00064521004,0.00022446206,0.000032215623,0.000006948242,0.00004897985,0.000057598718,0.0006848706],"category_scores_gemma":[0.00012221855,0.00010410314,0.00007495082,0.00015020398,0.00012289372,0.0001246767,0.000031836706,0.00012332237,6.854178e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054858923,0.00032154418,0.9925626,0.00013840874,0.00013601348,0.00023201703,0.00038187337,7.778809e-8,0.0000040823397,0.0000044601634,0.00012744367,0.0006056004],"study_design_scores_gemma":[0.007681357,0.001378602,0.98975,0.00017626445,0.000051742387,0.00003192701,0.00004047272,6.1368985e-7,0.0000834656,0.000010140885,0.0007171913,0.00007817619],"about_ca_topic_score_codex":0.010451421,"about_ca_topic_score_gemma":0.03389317,"teacher_disagreement_score":0.02344175,"about_ca_system_score_codex":0.00024179771,"about_ca_system_score_gemma":0.0004379945,"threshold_uncertainty_score":0.9961381},"labels":[],"label_agreement":null},{"id":"W4249611568","doi":"10.1016/s1873-9954(08)70025-9","title":"P014 IS SOCIOECONOMIC DEPRIVATION ASSOCIATED WITH A MORE SEVERE CROHN'S DISEASE ?","year":2008,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis Supplements","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Crohn's disease; Socioeconomic status; Medicine; Disease; Social deprivation; Internal medicine; Environmental health; Political science","score_opus":0.020073067888793022,"score_gpt":0.2737208167304118,"score_spread":0.2536477488416188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249611568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217075,0.00044784375,0.000036149882,0.0067654084,0.000046668898,0.00017811003,0.00009194549,0.000009509061,0.0002536401],"genre_scores_gemma":[0.99387145,0.00074697885,0.00012248756,0.004459881,0.00008108508,0.000009371908,0.00002061252,0.000009985784,0.0006781308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989576,0.000027314962,0.00038126364,0.00013212016,0.00027939214,0.00022232514],"domain_scores_gemma":[0.99914294,0.000048399557,0.00028296618,0.000081930586,0.00020801704,0.00023576248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008232295,0.0001345252,0.00037539747,0.000063408304,0.00020556788,0.000022909595,0.000055152264,0.000044181732,0.00045435224],"category_scores_gemma":[0.000057602923,0.00009254876,0.0000996521,0.000056151042,0.00012833453,0.0001494648,0.00004159367,0.0001375916,0.000006016863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021357494,0.00036291117,0.94456214,0.00006424776,0.00047204216,0.0035919456,0.00076429854,0.0000015160366,0.0000046801733,0.00007082322,0.046519376,0.0014502899],"study_design_scores_gemma":[0.00410031,0.00025424772,0.9790633,0.000107457876,0.00016564678,0.00055167865,0.00029033996,0.00001974871,0.000025042104,0.00045969288,0.014851975,0.000110559595],"about_ca_topic_score_codex":0.000017752609,"about_ca_topic_score_gemma":0.00000935969,"teacher_disagreement_score":0.03450118,"about_ca_system_score_codex":0.00008294963,"about_ca_system_score_gemma":0.00016143982,"threshold_uncertainty_score":0.49748385},"labels":[],"label_agreement":null}]}